Liver transplant recipients with a history of diabetes can be categorised into three groups: those with undiagnosed diabetes (HbA1c > 6.5%) or treatment‐naive individuals, those with a history of insulin therapy, and those with a history of oral antidiabetic medication use. This evidence concerns the gene INS and diabetes mellitus.